RENEWAL OF SOFTWARE LICENSE, MAINTENANCE AND SUPPORT FOR GENEDATA ANALYST (AMBIS 2253271)
ID: NOI-NIAID-25-2253271Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Software Publishers (513210)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract for the renewal of the Genedata Analyst software license, along with maintenance and support services. This procurement is essential for the ongoing bioinformatics and statistical analysis of large ‘multi-omics’ datasets, which are critical for understanding immune responses in human samples during influenza A virus vaccination and infection studies. The software plays a vital role in the research conducted by the Viral Pathogenesis and Evolution Section, aiding in the development of novel vaccines and antiviral therapies. Interested vendors must submit capability statements via the NIH electronic Simplified Acquisition Submission System (eSASS) by 4:00 PM EST on January 31, 2025, and can contact Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further information.

    Files
    Title
    Posted
    The document provides instructions for submitting quotes through the National Institutes of Health (NIH) electronic Simplified Acquisition Submission System (eSASS). It emphasizes that all quotes must be submitted electronically via eSASS, with no acceptance of faxed or emailed submissions. Offerors must adhere to specified deadlines, with late proposals being deemed unacceptable. For quote preparation, the document outlines the need to create distinct PDF or Word files for both Technical and Business Quotes without cross-referencing each other. Each quote must be individually formatted to enhance word searches, and any signature documents should be merged into these files. Furthermore, it specifies naming conventions for the files to ensure easy identification, recommending formats that incorporate the offeror's name, solicitation number, and type of proposal. Clarity in documentation and adherence to guidelines are stressed to facilitate a smooth submission process. Overall, this guide serves to streamline quote submissions for government contract opportunities, ensuring compliance with federal requirements.
    Similar Opportunities
    Brand-Name or Equal, Acquisition of Agilent Bioanalyzer 5200 Fragment analyzer system for ETB Group at NCATS.
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking responses for the acquisition of a Brand-Name or Equal Agilent Bioanalyzer 5200 Fragment Analyzer system for the ETB Group at the National Center for Advancing Translational Sciences (NCATS). The procurement includes the Bioanalyzer system, a computer and monitor, controller and analysis software, capillary array, and installation/familiarization services, which are crucial for nucleic acid quantification and characterization in biomedical research. This advanced equipment is essential for high-throughput separation and quantification of DNA and RNA, supporting NIH's mission to enhance health and reduce illness through innovative medical research. Interested vendors must submit their capability statements by January 27, 2025, at 9 am Eastern Time, to Contract Specialist Giuliana Faller at giuliana.faller@nih.gov.
    GOLD SERVICE PLAN ANNUAL RENEWAL FOR MICROBETA LUMIJET INSTRUMENTS
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the annual renewal of the Gold Service Plan for two Microbeta2 Lumijet instruments. This procurement aims to ensure reliable and reproducible data collection through preventive maintenance and repair services for the instruments, which are critical for research in viral gene expression and vaccine development. The awarded contract will cover a 12-month service plan, including one preventive maintenance visit and unlimited repair services, with the submission deadline set for January 22, 2025, at 1:00 PM EST. Interested vendors can contact Angela Puddy at angela.puddy@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further details.
    Notice of Intent for Preventative Maintenance and Repair for LSR Fortessa, FACSCanto II, and Various Lasers
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Becton, Dickinson and Company (BD Biosciences) for preventative maintenance and repair services for various scientific equipment. The procurement includes two preventive maintenance inspections, software updates, unlimited service visits by OEM technicians, guaranteed OEM replacement parts, and emergency response support compliant with Biosafety Level 2 standards. This maintenance is crucial for ensuring the operational efficiency and safety of research equipment used in critical health studies. Interested vendors may submit capability statements via the NIAID electronic Submission System by 10:00 AM EST on January 31, 2025, with all submissions referencing Solicitation Number NOI-NIAID-25-2251079. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    ANNUAL SERVICE PLAN FOR MOLECULAR DEVICES EQUIPMENT (SPECTRAMAX-L, 2 EA AND STAKMAX , 2 EA)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide an annual service plan for Molecular Devices equipment, including two SpectraMax L units and two StakMax units. The procurement requires a one-year service contract that includes preventive maintenance, OEM replacement parts, labor, and technical support, ensuring minimal downtime for essential laboratory equipment used in a Biosafety Level 2/3 facility. This service is critical for maintaining operational efficiency in research environments, with a performance period from April 1, 2025, to March 31, 2026. Interested vendors must submit their quotes by January 30, 2025, and can contact Dana Monroe at dana.monroe@nih.gov for further details.
    SPEEDBioSystems TURBO293 Transfection Reagents
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a procurement contract with SPEED BioSystems, LLC for the acquisition of TURBO293 Transfection Reagents. The requirement includes 46 units of the TURBO293 TRANSFECTION REAGENT (20ML), which are critical for ongoing research and development activities at the Vaccine Research Center in Bethesda, Maryland. This procurement is being conducted on a sole-source basis due to SPEED BioSystems, LLC being the sole owner and developer of the required reagents, ensuring continuity and compatibility with existing protocols. Interested vendors may submit their capabilities statements to Jessica Emerson at jessica.emerson@nih.gov by the specified deadline for consideration, although the government is under no obligation to award a contract based on the responses received.
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    GeminiBio GemCell TM Plus Xeno free Reagents.
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a fixed-price contract for the supply of GeminiBio GemCell TM Plus Xeno free reagents, essential for the Center for Cellular Engineering's operations in Bethesda, Maryland. The procurement aims to secure a reliable source of reagents critical for manufacturing human cell and tissue-based products used in clinical trials, as the Center has validated GeminiBio's products for compatibility with its processes. This acquisition is vital to prevent treatment delays for patients involved in clinical trials, as switching vendors would necessitate costly and time-consuming requalification. Interested parties capable of providing similar products must submit a capability statement by January 26, 2025, to Emeka Onyejekwe at emeka.onyejekwe@nih.gov.
    Notice of Intent to Sole Source – TheraDoc subscription
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) Clinical Center intends to award a firm fixed-price purchase order for subscription services related to the TheraDoc application, exclusively owned by Premier Healthcare LLC. This procurement aims to secure applications, support, maintenance, and training for the TheraDoc clinical surveillance solution, which is critical for enhancing healthcare delivery and patient safety. The acquisition will follow the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a sole-source solicitation due to the unique nature of the services required. Interested parties may express their capabilities and submit comments to the NIH by November 21, 2024, with inquiries directed to Ryssa Nix at Ryssa.nix@nih.gov.
    Acquisition of SomaScan 7K and 11K Assay Kits
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure fifty-nine (59) SomaScan 7K and/or 11K Assay Kits on a sole source basis from SomaLogic Operating Co., Inc. This acquisition is intended to support the Center for Human Immunology, Inflammation, and Autoimmunity (CHI) in their systems biology research, which involves measuring a wide range of proteins in various human biological samples to enhance understanding of the immune system and related diseases. The procurement aligns with federal initiatives to advance health science research capabilities, with an estimated delivery date for the products set for December 20, 2024, and a performance period from February 21, 2025, to February 20, 2026. Interested vendors may contact Kathy Song at kathy.song@nih.gov for further information and must submit their capabilities statements within 15 days of this notice.
    Diagnostic laboratory Testing
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Antech Diagnostics, Inc. for one year of diagnostic laboratory testing services at the NIH Animal Center in Poolesville, Maryland. The required services include clinical pathological evaluations of blood and other bodily fluids from non-human primates, encompassing tests such as Complete Blood Counts, Blood Chemistry Analysis, and Urinalysis, which are critical for ensuring accurate and timely results in research. This procurement is justified under the statutory authority allowing non-competitive procurement due to the necessity for continuity in laboratory services, and interested parties are invited to submit capability statements by January 23, 2023, to Calvin Robinson at calvin.robinson@nih.gov for consideration.